Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update)
- PMID: 15883407
- PMCID: PMC557103
- DOI: 10.1503/cmaj.045062
Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update)
References
-
- Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer. A Canadian consensus document. 9. Follow-up after treatment for breast cancer. CMAJ 1998;158(3 Suppl):S65-70. - PubMed
-
- Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002;20:1128-43. - PubMed
-
- Saarto T, Blomqvist C, Valimaki M, Makela P, Sarna S, Elomaa I. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol 1997;15:1341-7. - PubMed
-
- Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, et al; ATAC Trialists' Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005;365:60-2. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical